Stock Detail
NEURALSTEM INC
Sector: Biotechnology
Latest Quote @ Sun May 5 18:31:50 (15 min delayed)
| $1.49 |
$1.55 |
$1.49 |
+0.04 |
2.76% |
2.13M |
Last Day's Data
| $1.49 |
$1.59 |
$0.04 |
2.76% |
0.00 |
$1.45 |
| $1.52 |
$1.40 |
2.00 |
102.51M |
384,289.00 |
0.00 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 1.68 |
1.58 |
1.49 |
1.39 |
1.30 |
Stock Profile
Neuralstem, Inc., a biotechnology company, engages in developing and commercializing treatments based on transplanting human neural stem cells. The company uses its proprietary human neural stem cell technology to create biotherapeutic products for the treatment of central nervous system diseases and various neurodegenerative conditions, and for the regenerative repair of acute diseases. Its proprietary technology is also used in small-molecule drug discovery. The company was founded in 1996 and is headquartered in Rockville, Maryland.
